Clara Serger

4PUBLICATIONS
35CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 14, 2026
Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunity.

|Jun 05, 2026
Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer.

|Sep 17, 2025
PD-1-targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer.

Irene Fusi, Clara Serger, Petra Herzig

|Nov 17, 2024
Inhibition of Cbl-b restores effector functions of human intratumoral NK cells.

Sofia Tundo, Marcel Trefny, Andrijana Rodić

Pageof 1

Frequent Collaborators

4 joint publications

Alfred Zippelius

3 joint publications

Nicole Oelgarth

2 joint publications

Sofia Tundo

2 joint publications

Marcel Trefny